A
Overview
Abdiel Capital is a New York-based investment firm that makes concentrated, long-only bets on publicly traded companies. It looks for businesses likely to gain market share over long horizons, preferring recurring revenue and leaders who have a large personal stake in the stock. The firm usually invests most of its capital in its ten biggest bets and values a idea by the long-term cash-flow the whole business could generate if held forever. Its goal is to deliver solid absolute returns that beat the market over multi-year periods by focusing on strong leadership, durable franchises, and a high-conviction, long-term approach.
Work here?Claim your company
Simplify's take
What believers are saying
- OutSystems' October 2026 launch of Agent Experience extends Abdiel into AI infrastructure.
- OutSystems earned 2026 Gartner leader status and a $9.5 billion valuation, validating Abdiel's deal flow.
- HCA stayed Abdiel's largest holding in Q2 2026, anchoring returns with resilient healthcare cash flows.
What critics are saying
- Q1 2026, Abdiel exited Appian, Coupang, and BBB Foods; turnover destroys compounders.
- Q2 2026 portfolio held only five positions; one misstep can crush firm performance.
- OutSystems, Appian, and HCA concentration ties Abdiel's reputation to a few volatile names.
What makes Abdiel Capital unique
- Colin Moran and Geoffrey Gentile run a concentrated, founder-style portfolio, not diversified asset gathering.
- Abdiel co-led OutSystems' October 7, 2026 $150 million round at a $9.5 billion valuation.
- Q2 2026 holdings show HCA, AFRM, and GLBE dominate; Abdiel bets big on winners.
Help us improve and share your feedback! Did you find this helpful?